A rapid state-of the-art review of client-reported outcomes measures used to assess dogs' clinical signs and quality of life during chemotherapy

被引：0

作者：

Harris, Jenny ^{[1
]}

Fournier, Quentin ^{[2
]}

Sutton, Katie ^{[1
]}

Armes, Jo ^{[1
]}

Ream, Emma ^{[1
]}

Bacon, Nick ^{[2
,3
]}

机构：

[1] Univ Surrey, Fac Hlth & Med Sci, Sch Hlth Sci, Guildford, England

[2] AURA Vet, Guildford, England

[3] Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Guildford, England

来源：

BMC VETERINARY RESEARCH | 2025年 / 21卷 / 01期

关键词：

Adverse events; Veterinary oncology; Dogs; Chemotherapy; Quality of life; Client reported outcome measures; QUESTIONNAIRE; OWNERS; PERCEPTIONS; INSTRUMENT; PRIORITIES; TRIALS; EORTC; CATS; CARE;

D O I：

10.1186/s12917-025-04522-4

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

BackgroundQuality of life is an essential component of decision-making in veterinary oncology. Poor management of adverse events during chemotherapy can impair dogs' quality of life and be life-threatening. Consequently, client-reported outcome measures (CROMs) are being proposed to help assess both clinical signs and quality of life. The purpose of this rapid review was to: (1) identify existing CROMs that have been used to assess dogs' clinical signs and quality of life during chemotherapy; and (2) evaluate their methodological development to inform adaptation or development of a CROM for use in routine clinical practice, including remote monitoring. Databases (Scopus, Web of Science, PUBMED/MEDLINE) were searched for CROMs (questionnaires) completed by a non-expert family member about their companion dog. CROM content (domains measured) and scale quality were appraised.ResultsTen CROMs were identified and three were variations of the same tool. Content of the CROMs varied considerably (range 3-17 domains) with gastrointestinal being the most frequently measured clinical sign cluster (9/10 studies), followed by mobility/ambulatory activity (7/10) and global quality of life (6/10). No CROMs adhered to quality standards for the development of questionnaires and most failed to include qualitative design methods and basic psychometric assessment to ensure reliability and validity (such as internal consistency, test-retest reliability or factor analysis).ConclusionThe validity and reliability of existing chemotherapy CROMs for dogs remains under-tested. Although CROMs combined with remote digital monitoring have the potential to enhance patient care, as has been demonstrated with physician-based oncology, there is a need to apply quality standards to ensure optimal validation. Interdisciplinary collaborations would likely improve CROM quality and clinical utility thereby allowing veterinary healthcare professionals to better support their patients.

引用

页数：14